Anuradha Vasista

Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Bone Health Management in Men Commencing Androgen Deprivation Therapy for Prostate Cancer and Women Commencing Anti-Oestrogen Therapy for Breast Cancer.

Bone Health Management in Men Commencing Androgen Deprivation Therapy for Prostate Cancer and Women Commencing Anti-Oestrogen Therapy for Breast Cancer.

Journal: Cancer medicine

Published: September 12, 2024

Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy.

Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy.

Journal: The oncologist

Published: February 05, 2024

Coronary Flow Velocity Reserve Declines After Anthracycline Therapy in Breast Cancer Patients.

Coronary Flow Velocity Reserve Declines After Anthracycline Therapy in Breast Cancer Patients.

Journal: CJC open

Published: November 15, 2023

Beyond the median: Estimating survival times for patients starting endocrine therapy for estrogen receptor-positive, metastatic breast cancer from recent randomized trials.

Beyond the median: Estimating survival times for patients starting endocrine therapy for estrogen receptor-positive, metastatic breast cancer from recent randomized trials.

Journal: Asia-Pacific journal of clinical oncology

Published: September 18, 2023

Accuracy of oncologists' estimates of expected survival time in advanced cancer.

Accuracy of oncologists' estimates of expected survival time in advanced cancer.

Journal: JNCI cancer spectrum

Published: August 13, 2023

Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?

Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?

Journal: Internal medicine journal

Published: September 24, 2019

Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice.

Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice.

Journal: Asia-Pacific journal of clinical oncology

Published: May 06, 2019

Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.

Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.

Journal: The oncologist

Published: September 20, 2018

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials.

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials.

Journal: Breast (Edinburgh, Scotland)

Published: September 03, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026